Nasdaq

Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity Platform

IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance.
Nasdaq

Masimo to Integrate Imprivata Medical Device Access Authentication Technology into Its Root® and Iris® Hospital Automation Platform

With the addition of Imprivata Medical Device Access to Masimo Root and Iris Gateway, hospitals gain access to an even more powerful patient monitoring and hospital automation solution designed to ...
Business Wire

Masimo Launches Dual SET ® Pulse Oximetry

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced Dual SET ® Pulse Oximetry for Root ®, a highly versatile patient monitoring and connectivity hub. The first application ...
Business Wire

Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, ...
Seeking Alpha

Masimo Reports First Quarter 2025 Results

Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, ...